ERBB2 and breast carcinoma: It was also demonstrated that induction of ACTA2 by EGFR and HER2 dimerization is regulated through a JAK2/STAT1 signaling pathway and that abnormal ACTA2 expression accelerates the invasiveness and metastasis of breast cancer cells (Jeon et al., 2017).